FindMyRecallSubscribe
Class I: serious health riskTerminated

Aurobindo Pharma Lidocaine HCl Injection Recall

Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd

Aurobindo Pharma USA Inc. · East Windsor, NJ

Risk level
Class I
Reported by FDA
Apr 17, 2019
Recall ID
D-1248-2019
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Lidocaine HCl Injection starting Mar 28, 2019. The FDA classified it as Class I (serious health risk) and published enforcement report D-1248-2019 on Apr 17, 2019. Reason: Presence of Particulate Matter: One vial was found to contain a hair. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: One vial was found to contain a hair.

Product description

Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05

Lot numbers, UPCs & expiration codes

Lot #: CLC180117, Exp. June 2021

Where it was sold

Product is being held at a distributor site in Mexico, Asheboro, NC, Charlotte, NC and Santa Teresa, NM and not further distributed in the U.S. Market.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1248-2019
Classification
Class I
Status
Terminated
Recall initiated
Mar 28, 2019
FDA report date
Apr 17, 2019
Quantity
88600 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc.

Original FDA data

Every field from FDA enforcement report D-1248-2019, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
82496
Address
279 Princeton Hightstown Rd
Code information
Lot #: CLC180117, Exp. June 2021
Postal code
08520-1401
Report date
Apr 17, 2019
Product type
Drugs
Recall number
D-1248-2019
Classification
Class I
Recalling firm
Aurobindo Pharma USA Inc.
Product quantity
88600 vials
Termination date
Apr 11, 2024
Reason for recall
Presence of Particulate Matter: One vial was found to contain a hair.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05
Distribution pattern
Product is being held at a distributor site in Mexico, Asheboro, NC, Charlotte, NC and Santa Teresa, NM and not further distributed in the U.S. Market.
Recall initiation date
Mar 28, 2019
Initial firm notification
Letter
Center classification date
Apr 25, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1248-2019, published Apr 17, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls